mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |